SelectQuote, Inc. Form 8-K Summary
Business context and reporting period
SelectQuote, Inc. filed a Form 8-K on August 29, 2022, reporting events occurring August 26, 2022. The filing covers an amendment to the company’s senior secured credit facility and references financial results for the fourth quarter and fiscal year ended June 30, 2022. The related press release and investor presentation were furnished as exhibits, but their financial details are not included in the provided filing text.
Financial position, debt, and liquidity
- The company entered into a Fourth Amendment to its November 5, 2019 Credit Agreement.
- The amendment revises the existing financial covenant and adds a minimum liquidity covenant.
- Delayed draw term loan commitments were terminated, and revolving commitments were reduced from $135.0 million to $100.0 million.
- A minimum asset coverage ratio applies to revolving borrowings that would result in total revolving exposure above $50.0 million.
- Revolving borrowings bear interest, at the company’s option, at SOFR subject to a 1.0% floor plus 5.0%, or a base rate plus 4.0%.
- Term loans bear interest, at the company’s option, at SOFR subject to a 0.75% floor plus 6.0% cash interest and 2.0% payable-in-kind interest, or a base rate plus 5.0% cash interest and 2.0% payable-in-kind interest.
- Beginning October 1, 2023, the term-loan cash interest rate increases by 0.50% and the payable-in-kind rate increases by 1.00%.
- Consenting lenders received amendment fees equal to 1.00% of their term loans and 0.50% of their revolving commitments, measured after the amendment.
- The company must pay a $0.5 million revolving credit termination fee for each revolving lender if all revolving commitments are terminated.
- The credit obligations remain guaranteed by certain subsidiaries and secured by substantially all company assets, subject to specified exceptions.
- SelectQuote Ventures, Inc. and Population Health, Inc. became additional guarantors.
Material changes versus the prior arrangement
- Financial covenant requirements were revised to better align with the company’s business plan, and a minimum liquidity covenant was added.
- Revolving capacity was reduced by $35.0 million, from $135.0 million to $100.0 million.
- Delayed draw term loan commitments were terminated.
- New asset coverage requirements apply to certain higher levels of revolving exposure.
- Certain lenders received the right to appoint a representative to observe company board meetings.
- Term-loan pricing includes both cash and payable-in-kind interest and is scheduled to increase beginning October 1, 2023.
Outlook, risks, contingencies, and unusual items
The amendment indicates heightened lender protections and tighter liquidity and collateral requirements. Key risks include increased borrowing costs, the scheduled future step-up in term-loan interest rates, reduced revolving availability, amendment fees, and the potential $0.5 million-per-lender termination fee. The filing does not provide specific management guidance, revenue forecasts, profit figures, cash flow figures, margins, or operating commentary. It also does not provide the detailed fourth-quarter or full-year results referenced in the exhibits.
Important facts for investors to verify
- Review Exhibits 99.1 and 99.2 for the actual fourth-quarter and fiscal-year financial results, liquidity, cash flow, margins, and management outlook.
- Verify the outstanding term-loan and revolving balances, covenant thresholds, and available borrowing capacity under the amended facility.
- Assess compliance with the revised financial and minimum liquidity covenants.
- Evaluate the impact of the 2023 interest-rate step-up and payable-in-kind interest on future cash requirements and debt balances.
- Review the complete Fourth Amendment, including omitted schedules and collateral, guaranty, lender-observer, and termination-fee provisions.